Best 3-Year Risk-Adjusted Returns in Multi-Cap Growth Category
TGFRX up 71.9% in 3-Years Through 11/30/23 vs. 32.2% for the S&P 500
At TCM we look for under-appreciated and undervalued growth companies with proprietary platforms that can proliferate multiple products and services and generate growth for several years. We also seek companies which are undergoing change that will lead to better than expected earnings over the next 2-5 years.
We have a history of investing in companies with proprietary platforms that can generate innovative new products and services over multiple years and deliver outsized compound stock returns. We were early in discovering Aflac who disrupted the supplemental insurance market with its cancer insurance platform, as well as Intel whose continuous advancement of its microprocessors (Moore's Law) helped to pioneer the Digital Revolution.
Other investments include:
Our focus includes original top down macroeconomic research and "bottoms up" stock selection. Our proprietary economic analysis in areas such as demographics, inflation, productivity, monetary and fiscal policy as well as technology and the economy has enabled us to focus on certain industries or companies that will benefit disproportionally from fundamental strategic change and become more profitable.
We perform "kick the tires" research to find out what is really going on in a target company. This requires meeting management, asking better questions to get better answers, and shopping the product or service as consumers. We see hundreds of managements a year, generating new candidates that challenge existing positions and keep the portfolio fresh.